 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Shannon Hader (born July 15, 1968) is an American public health physician who is the Dean of the School of International Service at American University. She is a published scientist and doctor, primarily focused on the HIV and AIDS epidemic. Her research specializes in infectious diseases. [1]
Hader received a Bachelor of Science in biological sciences from Stanford University and her Masters of Public Health and Doctorate from Columbia University College of Physicians and Surgeons. [2]
She conducted her residency at Duke University School of Medicine and participated in the Infectious Disease Fellowship at Emory University School of Medicine. She later received a certificate in Leadership Coaching from Georgetown University. [3]
From 2003 to 2006, Hader served as the Director of CDC-Zimbabwe. [4] In 2007, until 2010, Hader held the position of Senior Deputy Director, HIV/AIDS, Hepatitis, STD and TB Administration for the District of Columbia. [5] There, she advised city officials on specific response tactics and increased education on HIV/AIDS. [6]
Afterwards, she was vice president and Director of Center for Health Systems and Solutions at Futures Group, now known as Palladium, into 2014. [7] While working at Palladium, she took a sabbatical in 2013 to work as a Health Policy Fellow at the Robert Wood Johnson Foundation under Senator Ed Markey. [8] [9]
In 2014, Hader was appointed Director of the Division of Global HIV and TB at the US Centers for Disease Control and Prevention (CDC). [2] She helped implement the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) to collect more data and increase global access to life-saving HIV treatment. [10]
In 2018, Hader ran as a Democrat for the US House of Representatives to represent Washington's 8th Congressional District. [11] [12] [13]
From 2019 to 2021, Hader served as an Assistant Secretary General at the United Nations and Deputy Executive Director for Program at UNAIDS. [14] [15]
Starting in 2022, Hader has worked at American University as Dean & Professor of the School of International Service. [16]
The Joint United Nations Programme on HIV and AIDS is the main advocate for accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic.
World AIDS Day, designated on 1 December every year since 1988, is an international day dedicated to raising awareness of the AIDS pandemic caused by the spread of HIV infection and mourning those who've died of the disease. The acquired immunodeficiency syndrome (AIDS) is a life-threatening condition caused by the human immunodeficiency virus (HIV). The HIV virus attacks the immune system of the patient and reduces its resistance to other diseases. Government and health officials, non-governmental organizations, and individuals around the world observe the day, often with education on AIDS prevention and control.
Julie Louise Gerberding is an American infectious disease expert who was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). As of May 2022, she is the CEO of the Foundation for the National Institutes of Health (FNIH). Gerberding grew up in Estelline, South Dakota, attended Brookings High School, and earned undergraduate and graduate degrees from Case Western Reserve University. She was the chief medical resident at the University of California, San Francisco where she treated hospitalized AIDS patients in the first years of the epidemic. Gerberding became a nationally-recognized figure during the 2001 anthrax attacks in the United States during her tenure as the acting deputy director of the National Center for Infectious Diseases, where she was a prominent spokeswoman for the CDC during daily briefings regarding the attacks and aftermath. Gerberding then served as CDC director from 2002-2009, and was then hired as an administrator at Merck.
The United States President's Emergency Plan For AIDS Relief (PEPFAR) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003, as of May 2020, PEPFAR has provided about $90 billion in cumulative funding for HIV/AIDS treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2023, PEPFAR has saved over 25 million lives, primarily in sub-Saharan Africa.
The global pandemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), by 2023, HIV/AIDS had killed approximately 40.4 million people, and approximately 39 million people were infected with HIV globally. Of these, 29.8 million people (75%) are receiving antiretroviral treatment. There were about 630,000 deaths from HIV/AIDS in 2022. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2020, there are approximately 1.5 million new infections of HIV per year globally.
The Centre for Infectious Disease Research in Zambia (CIDRZ) is a non-profit organisation founded in 2001 as collaboration between the University of Alabama at Birmingham, USA, the Ministry of Health of Zambia and the University of Zambia School of Medicine. In 2011 CIDRZ became an independent, Zambian, non-governmental organisation able to collaborate with multiple local and international universities.
The Democratic Republic of the Congo was one of the first African countries to recognize HIV, registering cases of HIV among hospital patients as early as 1983.
HIV/AIDS in Eswatini was first reported in 1986 but has since reached epidemic proportions. As of 2016, Eswatini had the highest prevalence of HIV among adults aged 15 to 49 in the world (27.2%).
UNAIDS has said that HIV/AIDS in Indonesia is one of Asia's fastest growing epidemics. In 2010, it is expected that 5 million Indonesians will have HIV/AIDS. In 2007, Indonesia was ranked 99th in the world by prevalence rate, but because of low understanding of the symptoms of the disease and high social stigma attached to it, only 5-10% of HIV/AIDS sufferers actually get diagnosed and treated. According to the a census conducted in 2019, it is counted that 640,443 people in the country are living with HIV. The adult prevalence for HIV/ AIDS in the country is 0.4%. Indonesia is the country in Southeast Asia to have the most number of recorded people living with HIV while Thailand has the highest adult prevalence.
Eric Goosby is an American public health official, currently serving as the UN Special Envoy on Tuberculosis. Goosby previously served as the United States Global AIDS Coordinator from 2009 until mid-November 2013. In the role, Goosby directed the U.S. strategy for addressing HIV around the world and led President Obama's implementation of the President's Emergency Plan for AIDS Relief (PEPFAR). Goosby was sworn in during June 2009 and resigned in November 2013, taking a position as a professor at UCSF, where he directs the Center for Global Health Delivery and Diplomacy, a collaboration between UCSF and the University of California, Berkeley.
United Nations Security Council resolution 1308, adopted unanimously on 17 July 2000, was the first resolution to address the impact of HIV/AIDS worldwide. The Security Council asked countries to consider voluntary HIV/AIDS testing and counselling for troops deployed in peacekeeping operations.
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.
James W. Curran is professor of epidemiology and dean of the Rollins School of Public Health at Emory University. He is an adjunct Professor of Medicine and Nursing, and Co-Director and Principal Investigator of the Emory Center for AIDS Research. He is immediate past chair of the board on Population Health and Public Health Practice of the Institute of Medicine and served on the Executive Committee of the Association of Schools of Public Health. Additionally, he holds an endowed chair known as the James W. Curran Dean of Public Health. Curran is considered to be a pioneer, leader, and expert in the field of HIV/AIDS.
Emily J. Erbelding is an American physician-scientist. She is the director of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Erbelding was previously deputy director of the Division of AIDS at NIAID. She was a faculty member at Johns Hopkins School of Medicine and served as director of clinical services for the Baltimore City Health Department STD/HIV program.
David "Davey" M. Smith, is an American translational research virologist, chief of the Division of Infectious Diseases and Global Public Health at the University of California San Diego, co-director of the San Diego Center for AIDS Research, and vice chair of research in the Department of Medicine at UC San Diego. His research interests include transmission, prevention, and treatment of both HIV and SARS-CoV2 (COVID-19). Since joining the UC San Diego faculty in 2003, Smith has been awarded more than $37 million in federal funding as a principal investigator. His research interests include transmission, prevention, and treatment of both HIV and COVID-19.
Monica Gandhi is an American physician and professor. She teaches medicine at the University of California, San Francisco (UCSF) and is director of the UCSF Gladstone Center for AIDS Research and the medical director of the San Francisco General Hospital HIV Clinic, Ward 86. Her research considers HIV prevalence in women, as well as HIV treatment and prevention. She has been noted as a critic of some aspects of the COVID-19 lockdowns in the US.
John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022, as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.
Judith Aberg is an American physician who is the George Baehr Professor of Clinical Medicine at Mount Sinai Hospital. She was appointed Dean of System Operations for Clinical Sciences at the Icahn School of Medicine at Mount Sinai. Her research considered infectious diseases, including HIV/AIDS and COVID-19.
Virginia A. Caine is an American physician who is the director and chief medical officer of the Marion County Public Health Department in Indianapolis, Indiana. She is a specialist in infectious diseases and is nationally recognized for her work with AIDS and sexually transmitted diseases. She is an Associate Professor of Medicine for the Infectious Disease Division of the Indiana University School of Medicine and an Adjunct Associate Professor in the School of Public Health.